1,1-Dioxido-2-(4-bromobutyl)-1,2-benzisothiazol-3(2H)-one → HCID 19085832, compound
Reaction equation
[CH3:1][C:2]1[CH:3]=[C:4]([CH3:18])[C:5]2[O:9][C:8](=[O:10])[N:7]([CH:11]3[CH2:16][CH2:15][NH:14][CH2:13][CH2:12]3)[C:6]=2[CH:17]=1.Br[CH2:20][CH2:21][CH2:22][CH2:23][N:24]1[C:28](=[O:29])[C:27]2[CH:30]=[CH:31][CH:32]=[CH:33][C:26]=2[S:25]1(=[O:35])=[O:34]>>[O:34]=[S:25]1(=[O:35])[C:26]2[CH:33]=[CH:32][CH:31]=[CH:30][C:27]=2[C:28](=[O:29])[N:24]1[CH2:23][CH2:22][CH2:21][CH2:20][N:14]1[CH2:15][CH2:16][CH:11]([N:7]2[C:6]3[CH:17]=[C:2]([CH3:1])[CH:3]=[C:4]([CH3:18])[C:5]=3[O:9][C:8]2=[O:10])[CH2:12][CH2:13]1Participants
3
Procedure
From the hydrochloride salt of 4-(5,7-dimethyl-2-oxo-3-benzoxazolinyl)-piperidine and 2-(4-bromobutyl)-1,1-dioxido-1,2-benzothiazol-3(2H)-one using the procedure described for Example 15, Step 5 there was obtained a white solid: 1H NMR (300 MHz, CDCl3) 8.08 (d, J=7.27 Hz, 1H), 7.90 (m, 3H), 7.65 (br m, 1H), 6.752 (s, 1H), 4.55 (br m, 1H), 3.85 (br t, 2H), 3.70 (br m, 2H), 3.32 (br m, 2H), 3.10 (br m, 2H), 2.87 (br m, 2H), 2.413 (s, 3H), 2.318 (s, 3H), 2.06 (br m, 6H).
Workup
- customwas obtained a white solid
Sources & evidence
- ORD record
- ord-562f8e3c63cd4db38fed98cfd00e2f6b
- Source dataset
- uspto-grants-1998_06
- Patent number
- US05760054
Reaction notes
Loading…